raloxifene hydrochloride has been researched along with Overweight in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 2 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Kim, JH; Kim, YJ | 1 |
2 other study(ies) available for raloxifene hydrochloride and Overweight
| Article | Year |
|---|---|
Effects of genistein in combination with conjugated estrogens on endometrial hyperplasia and metabolic dysfunction in ovariectomized mice.
Topics: Adiposity; Animals; Diet, High-Fat; Dietary Supplements; Endometrial Hyperplasia; Endometrium; Estrogen Replacement Therapy; Estrogens; Estrogens, Conjugated (USP); Female; Genistein; Glucose Intolerance; Liver; Mice, Inbred C57BL; Non-alcoholic Fatty Liver Disease; Ovariectomy; Overweight; Phytoestrogens; Raloxifene Hydrochloride; Random Allocation; Selective Estrogen Receptor Modulators | 2015 |
Breast cancer facts.
Topics: Age Distribution; Breast Neoplasms; Breast Neoplasms, Male; Early Detection of Cancer; Estrogen Replacement Therapy; Exercise; Female; Humans; Male; Overweight; Raloxifene Hydrochloride; Risk Factors; Selective Estrogen Receptor Modulators; Survival Rate; Tamoxifen; United States | 2012 |